Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
79,418,794
-
Share change
-
+10,629,327
-
Total reported value
-
$574,182,277
-
Put/Call ratio
-
70%
-
Price per share
-
$7.23
-
Number of holders
-
126
-
Value change
-
+$77,465,831
-
Number of buys
-
66
-
Number of sells
-
35
Institutional Holders of KERYX BIOPHARMACEUTICALS - COMMON STOCK (KERX) as of Q2 2017
As of 30 Jun 2017,
KERYX BIOPHARMACEUTICALS - COMMON STOCK (KERX) was held by
126 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
79,418,794 shares.
The largest 10 holders included
BAUPOST GROUP LLC/MA, VANGUARD GROUP INC, Consonance Capital Management LP, ABRAMS CAPITAL MANAGEMENT, L.P., BlackRock Inc., STATE STREET CORP, FMR LLC, NORGES BANK, MILLENNIUM MANAGEMENT LLC, and RICE HALL JAMES & ASSOCIATES, LLC.
This page lists
126
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.